Dublin, July 12, 2018 (GLOBE NEWSWIRE) -- The "Transplant Diagnostics Market by Technology, Product, Application, Type, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.
Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, the high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.
This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products. Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables. On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation. Based on application, the market is categorized into diagnostic and research applications. The diagnostic applications segment accounted for the largest share of the market in 2018. The rising incidence of chronic diseases (that often lead to transplantation in critical and terminal patients) and greater risk of genetic disorders and pathogenic infections after transplantation (due to weaker immunity in geriatric recipients and discovery of novel biomarkers to identify genetic disorders) are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications. Based on end user, the market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching, growing number of organ transplantation procedures, and growing inauguration & accreditation of diagnostic laboratories across emerging as well as developed countries. This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.
Key Topics Covered
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Geographic Scope 1.3.3 Years Considered for the Study 1.4 Currency Used for the Study 1.5 Major Market Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.2 Primary Data 2.2 Market Size Estimation 2.2.1 Product-Based Market Estimation 2.2.2 Procedure Based Market Estimation 2.2.3 Primary Research Validation 2.3 Data Triangulation 2.4 Research Assumptions 2.5 Research Limitations 3 Executive Summary 4 Premium Insights 4.1 Transplant Diagnostics Market Overview 4.2 Market, By Technology 4.3 Regional Analysis: Market, By Application 4.4 Asia Pacific: Market, By End User, 2018 4.5 Regional Analysis: Market, By Product & Service 4.6 Regional Analysis: Market, By Transplant Type 4.7 Transplant Diagnostics Market, By Country 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Key Market Drivers 5.2.1.1 Increasing Number of Transplant Procedures 5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics 5.2.1.3 Increasing Public-Private Funding for Target Research Activities 5.2.1.4 Growing Burden of Infectious Diseases 5.2.2 Key Market Restraints 5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays 5.2.2.2 Limited Reimbursements for Target Procedures 5.2.3 Key Market Opportunities 5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation 5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries 5.2.4 Key Market Challenges 5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually 5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening 6 Transplant Diagnostics Market, By Product and Services 6.1 Introduction 6.2 Reagents and Consumables 6.3 Instruments 6.4 Software and Services 7 Transplant Diagnostics Market, By Technology 7.1 Introduction 7.2 Molecular Assays 7.2.1 PCR-Based Molecular Assays 7.2.1.1 Real-Time PCR 7.2.1.2 Sequence-Specific Primer-PCR 7.2.1.3 Sequence-Specific Oligonucleotide-PCR 7.2.1.4 Other PCR-Based Molecular Assays 7.2.2 Sequencing-Based Molecular Assays 7.2.2.1 Sanger Sequencing 7.2.2.2 Next-Generation Sequencing 7.2.2.3 Other Sequencing Molecular Assays 7.3 Non-Molecular Assays 8 Transplant Diagnostics Market, By Transplant Type 8.1 Introduction 8.2 Solid Organ Transplantation 8.2.1 Kidney Transplantation 8.2.2 Liver Transplantation 8.2.3 Heart Transplantation 8.2.4 Lung Transplantation 8.2.5 Pancreas Transplantation 8.2.6 Other Organ Transplantations 8.3 Stem Cell Transplantation 8.4 Soft Tissue Transplantation 9 Transplant Diagnostics Market, By Application 9.1 Introduction 9.2 Diagnostic Applications 9.2.1 Pre-Transplantation Diagnostics 9.2.1.1 Infectious Disease Testing 9.2.1.2 Histocompatibility Testing 9.2.1.3 Blood Profiling 9.2.2 Post-Transplantation Diagnostics 9.3 Research Applications 10 Transplant Diagnostics Market, By End User 10.1 Introduction 10.2 Independent Reference Laboratories 10.3 Hospitals & Transplant Centers 10.4 Research Laboratories & Academic Institutes 11 Transplant Diagnostics Market, By Region 11.1 Introduction 11.2 North America 11.2.1 US 11.2.2 Canada 11.3 Europe 11.3.1 Germany 11.3.2 UK 11.3.3 France 11.3.4 Rest of Europe 11.4 Asia Pacific 11.4.1 Japan 11.4.2 China 11.4.3 India 11.4.4 Rest of Asia Pacific 11.5 Rest of the World 12 Competitive Landscape 12.1 Overview 12.2 Market Share Analysis 12.3 Competitive Scenario 12.3.1 Key Product Launches and Enhancements (2014 to 2018) 12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018) 12.3.3 Major Acquisitions (2014 to 2018) 12.3.4 Key Expansions (2014 to 2018) 13 Company Profiles 13.1 Introduction 13.2 Becton, Dickinson and Company 13.3 Biofortuna 13.4 Biomrieux SA 13.5 Bio-Rad Laboratories 13.6 Caredx 13.7 F. Hoffman-La Roche Limited 13.8 Gendx 13.9 Hologic 13.10 Illumina 13.11 Immucor 13.12 Luminex 13.13 Merck KGaA 13.14 Omixon 13.15 Qiagen 13.16 Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/8...plant?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Diagnostics
